Novo Nordisk and HITLAB Team Up for Fourth Annual Innovators Summit

Wednesday, October 4, 2017 Education News
Email Print This Page Comment bookmark
Font : A-A+

Registration Now Open for Three-Day Digital Health Event

NEW YORK, Oct. 4, 2017 /PRNewswire-USNewswire/ -- HITLAB (Health Innovation Technology Lab, Inc.) announced its fourth

annual 2017 HITLAB Innovators Summit: New York, sponsored by Novo Nordisk. The three-day event in New York City will begin on Tuesday, November 28, and gather leaders in life sciences, public health, medicine, technology, and design to discuss health issues and digital solutions.

Topics covered will range from implementing entrepreneurial principles in life science companies to mergers and acquisitions and emerging trends in digital health.

"Attendees can expect curated talks and opportunities to connect with those pushing the envelope in digital health," said Stan Kachnowski, HITLAB chair. "This year, we're seeing speakers and attendees who represent the most influential organizations in this space. It's especially encouraging to see such a diverse group making strides in digital health diffusion."

The second day of the event will feature the 2017 HITLAB World Cup of Voice-Activated Technology in Diabetes presented by Novo Nordisk, a contest open to digital health innovators and entrepreneurs focused on voice-activated projects. Finalists will make pitches to the judging panel, and five cash prizes totaling $75,000 will be awarded. Judges represent companies including Google and Novo Nordisk.

"Novo Nordisk is excited to sponsor the Innovators Summit: New York, as well as this year's HITLAB World Cup of Voice-Activated Technology, focused on diabetes innovations," said David Moore, Senior Vice President, Commercial, Novo Nordisk. "At Novo Nordisk, we are constantly striving to address the unmet needs of patients, and we believe that digital health should be at the forefront of ongoing efforts to improve the lives of people living with diabetes."

Early bird tickets for the 2017 HITLAB Innovators Summit: New York, sponsored by Novo Nordisk are now available for purchase. Learn more about the event, agenda, and sponsors here. HITLAB is still accepting sponsors and partners.


HITLAB is an innovation and teaching lab dedicated to improving the quality and accessibility of healthcare worldwide. We help leading organizations ideate, create, and evaluate technology-based solutions to pressing healthcare challenges.

Our team of public health professionals, statisticians, clinicians, engineers, economists, strategists, designers, and anthropologists is determined to address healthcare needs across the globe. We work with a wide variety of stakeholders in both the public and private sectors to design and disseminate studies, programs, and products that improve healthcare access and delivery.

Every year, the Lab hosts the HITLAB Innovators Summit, which brings together leaders in public health, medicine, technology, and design to discuss health issues and solutions in a two-day live event. The Summit offers a series of carefully curated talks, panels, and collaboration opportunities to engage the most creative minds in health and technology. It culminates in the HITLAB World Cup, an international challenge of unparalleled diversity where innovators present original solutions to pressing global healthcare challenges.

For more information, please visit or follow the company on Twitter @HITLabNYC.

About Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity. With U.S. headquarters in Plainsboro, N.J., Novo Nordisk Inc. has nearly 5,000 employees in the United States.

For more information, visit or follow the company on Twitter: @novonordiskus.


View original content:

SOURCE Healthcare Innovation and Technology Lab

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store